Industry
The Microbiome Movement was founded in 2016 by Alexander Puttick and his colleagues from Hanson Wade in London. Now Alexander Puttick's invitation is to participate in upcoming events.
IPA (International Probiotics Association) Europe is a non-profit international organization of leading European companies in the probiotic field. We discuss IPA's role with its president Esben Laulund.
We discussed the correlation between metabolic syndrome and synbiotic supplementation with Arrigo F. G. Cicero, professor at the University of Bologna and president of the Italian Society of Nutraceuticals.
Katayoun Welin Berger, BioGaia's Vice President Operations, tells us about the activities of the company.
The microbiome may be a source for biomarkers leading to therapeutic discoveries and diagnostics. We discuss it with Emily Hollister, Vice President of Diversigen.
Richard Ellis, Head of Business Development at Biose, explains how CDMO companies assist start-ups in bringing live biotherapeutic products to the market.
Travis Whitfill, Co-Founder and CSO of Azitra, explains how Staphylococcus epidermidis-based products may treat various skin conditions and diseases.
Probiotics: 2019 will be crucial for scientific and regulatory aspects with help coming also from Venture Capital. Denise Kelly from Seventure talks about it.
The development of probiotics presents major regulatory challenges. We discussed it this Clara Desvignes from Voisin Consulting Life Sciences.
New technologies such as the analysis of the "aquatic microbiota" allow to dig deeply into the microbiome chemistry. We discuss this approach with Ross Youngs, CEO of Biosortia.
